Learn More
Description
Rapid diagnosis of Legionnaires’ disease and early initiation of appropriate therapy has been shown to dramatically reduce morbidity and mortality. This rapid assay is used in urine samples from patients with symptoms of pneumonia. It is intended to aid in the presumptive diagnosis of Legionnaires’ disease caused by L. pneumophila serogroup 1 in conjunction with culture and other methods.
- Highly accurate – 95% sensitivity and specificity; treat with confidence
- Easy-to-use – Easy to manage and train; minimizes operator error
- Results in 15 minutes or less – Faster throughput in lab or Emergency Department, aiding in rapid, focused therapy
- Room temperature storage – Doesn’t take up valuable refrigerator space
- Recommended as part of the IDSA/ATS CAP Guidelines
- Decrease number of broad-spectrum antibiotics prescribed
- Shorten patient wait time/hospital stay
- Decrease need for unnecessary ancillary testing
- Improve patient outcomes through rapid, focused therapy
Order Info
For control swabs to be used with this test, see Cat. No. BNX852010
Specifications
Specifications
| Clia Complexity | Moderate |
| Sample Type | Urine |
| Type | BinaxNOW™ Legionella Urinary Antigen Card |
| For Use With (Application) | Qualitative detection of Legionella pneumophila serogroup 1 Antigen in Urine specimens |
| Quantity | 22 Tests |
| Test Time | 15 min. |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.